This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated Sep 2026 quarter revenue up 24.4 percent; profit after tax positive vs year-ago loss
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts less than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated revenue for the quarter ended September 30, 2026 was Rs 1,244.93 lakh, up 24.4 percent from Rs 1,001.07 lakh a year earlier; profit after tax was Rs 115.20 lakh versus a Rs 11.98 lakh loss. The operating margin before other income, interest, depreciation and tax rose from 11.5 percent to 22.8 percent. The limited review flagged missing inventory movements in the standalone register and reliance on unreviewed subsidiary accounts.
The strong quarter may support sentiment, but missing inventory movement details and reliance on unreviewed subsidiary accounts remain risks.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹12.45 Cr | ₹10.01 Cr | +24.4% |
| Operating profit | ₹1.63 Cr | ₹0.38 Cr | +324.7% |
| Profit after tax | ₹1.15 Cr | −₹0.12 Cr | turned positive |
| EBITDA margin | 22.9% | 11.5% | +11.3 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.